These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5479011)

  • 41. 9 -Tetrahydrocannabinol and its metabolites in monkey brains.
    Ho BT; Estevez V; Englert LF; McIsaac WM
    J Pharm Pharmacol; 1972 May; 24(5):414-6. PubMed ID: 4403817
    [No Abstract]   [Full Text] [Related]  

  • 42. Delta-9-tetrahydrocannabinol: localization in body fat.
    Kreuz DS; Axelrod J
    Science; 1973 Jan; 179(4071):391-3. PubMed ID: 4682965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. (-)- s -tetrahydrocannabinol: two novel in vitro metabolites.
    Maynard DE; Gurny O; Pitcher RG; Kierstead RW
    Experientia; 1971 Oct; 27(10):1154-5. PubMed ID: 5127857
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma cannabinoids measured by radioimmunoassay in rabbits after intravenous injection of tetrahydrocannibinol, 11-hydroxy-tetrahydrocannabinol, cannabinol and cannabidiol.
    Teale JD; Clough JM; Piall EM; King LJ; Marks V
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):339-42. PubMed ID: 1153879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism and distribution of cannabinoids in rats after different methods of administration.
    Leighty EG
    Biochem Pharmacol; 1973 Jul; 22(13):1613-21. PubMed ID: 4729809
    [No Abstract]   [Full Text] [Related]  

  • 46. Tolerance and disposition of tetrahydrocannabinol in man.
    Hunt CA; Jones RT
    J Pharmacol Exp Ther; 1980 Oct; 215(1):35-44. PubMed ID: 6256518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The disposition of clavulanic acid in man.
    Bolton GC; Allen GD; Davies BE; Filer CW; Jeffery DJ
    Xenobiotica; 1986 Sep; 16(9):853-63. PubMed ID: 3765664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delta-9-tetrahydrocannabinol. Temporal correlation of the psychologic effects and blood levels after various routes of administration.
    Lemberger L; Weiss JL; Watanabe AM; Galanter IM; Wyatt RJ; Cardon PV
    N Engl J Med; 1972 Mar; 286(13):685-8. PubMed ID: 5061055
    [No Abstract]   [Full Text] [Related]  

  • 49. Distribution of delta 9-tetrahydrocannabinol in the mouse.
    Freudenthal RI; Martin J; Wall ME
    Br J Pharmacol; 1972 Feb; 44(2):244-9. PubMed ID: 4668591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol.
    McCallum ND; Yagen B; Levy S; Mechoulam R
    Experientia; 1975 May; 31(5):520-1. PubMed ID: 1140243
    [No Abstract]   [Full Text] [Related]  

  • 51. Disposition and excretion of 14C-AHTN (7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphthalene) and 14c-hhcb (1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-cyclopenta-gamma-2-benzopyran) after intravenous administration to Sprague-Dawley rats and domestic pigs.
    Api AM; Ritacco G; Sipes IG
    Int J Toxicol; 2013 Jul; 32(4):288-95. PubMed ID: 23685777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of ( 14 C)methamphetamine in man, the guinea pig and the rat.
    Caldwell J; Dring LG; Williams RT
    Biochem J; 1972 Aug; 129(1):11-22. PubMed ID: 4646771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disposition and metabolism of darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in humans.
    Dave M; Nash M; Young GC; Ellens H; Magee MH; Roberts AD; Taylor MA; Greenhill RW; Boyle GW
    Drug Metab Dispos; 2014 Mar; 42(3):415-30. PubMed ID: 24378325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excretion of THC and its metabolites in ewes' milk.
    Jakubovic A; Tait RM; McGeer PL
    Toxicol Appl Pharmacol; 1974 Apr; 28(1):38-43. PubMed ID: 4859325
    [No Abstract]   [Full Text] [Related]  

  • 55. Metabolism and disposition of l-alpha-acetylmethadol in the rat.
    Henderson GL; North-Root H; Kuttab SH
    Drug Metab Dispos; 1977; 5(4):321-8. PubMed ID: 19211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of a potential urinary tetrahydrocannabinol metabolite.
    Nilsson JL; Nilsson IM; Agurell S; Ben-Zvi Z; Mechoulam R
    Acta Pharm Suec; 1972 Jun; 9(3):215-20. PubMed ID: 5053671
    [No Abstract]   [Full Text] [Related]  

  • 57. The metabolic fate of 2H-labelled propafenone in man.
    Hege HG; Hollmann M; Kaumeier S; Lietz H
    Eur J Drug Metab Pharmacokinet; 1984; 9(1):41-55. PubMed ID: 6714269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in vitro and in vivo metabolism of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP).
    Lemberger L; McMahon RE; Archer RA; Matsumoto K; Rowe H
    J Pharmacol Exp Ther; 1973 Oct; 187(1):169-75. PubMed ID: 4746325
    [No Abstract]   [Full Text] [Related]  

  • 59. Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man.
    Purnell WD; Gregg JM
    Ann Ophthalmol; 1975 Jul; 7(7):921-3. PubMed ID: 1147519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole-body autoradiography of 1-tetrahydrocannabinol and 1(6)-tetrahydrocannabinol in mouse. Pharmacokinetic aspects of 1-tetrahydrocannabinol and its metabolites.
    Ryrfeldt A; Ramsay CH; Nilsson IM; Widman M; Agurell S
    Acta Pharm Suec; 1973 Mar; 10(1):13-28. PubMed ID: 4196483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.